Goldman Sachs reports sale of 105,807 Attovia Therapeutics shares worth $2.22 million

Reuters2026/08/14 01:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Goldman Sachs reported trading activity in Attovia Therapeutics common stock on Aug. 5, 2026.
Purchased 85,000 shares at USD 21.
Sold 105,807 shares at prices from USD 20.84 to USD 22.11.
Reported holdings from that activity fell to zero by end of Aug. 5.
On Aug. 6, it acquired 2.44 million shares via preferred-stock conversions, lifting beneficial ownership to 3.02 million shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Attovia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000886982-26-000495), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Goldman Sachs reports sale of 105,807 Attovia Therapeutics shares worth $2.22 million

You may also like

Crypto prices